Cargando…

Anxiety and depression affect performance on the symbol digit modalities test over time in MS and other immune disorders

BACKGROUND: Longitudinal studies assessing depression and anxiety effects on cognition in multiple sclerosis (MS) are limited. OBJECTIVE: We tested whether within-person fluctuations in symptoms of depression or anxiety over time affect cognition in persons with MS, inflammatory bowel disease (IBD),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marrie, Ruth Ann, Patel, Ronak, Bernstein, Charles N, Bolton, James M, Graff, Lesley A, Marriott, James J, Hitchon, Carol A, Figley, Chase R, Kornelsen, Jennifer, Fisk, John D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226371/ https://www.ncbi.nlm.nih.gov/pubmed/32976067 http://dx.doi.org/10.1177/1352458520961534

Ejemplares similares

Performance of Regression-Based Norms for Cognitive Functioning of Persons With Multiple Sclerosis in an Independent Sample
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Vascular comorbidity is associated with decreased cognitive functioning in inflammatory bowel disease
por: Patel, Ronak, et al.
Publicado: (2023)

Effects of Vascular Comorbidity on Cognition in Multiple Sclerosis Are Partially Mediated by Changes in Brain Structure
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Within-person fluctuations over three years in depression, anxiety, fatigue, and health-related quality of life in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Differences in resting state functional connectivity relative to multiple sclerosis and impaired information processing speed
por: Carter, Sean L., et al.
Publicado: (2023)

Well-being and flourishing mental health in adults with inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis in Manitoba, Canada: a cross-sectional study
por: Almweisheer, Shaza, et al.
Publicado: (2023)

Pain and participation in social activities in people with relapsing remitting and progressive multiple sclerosis
por: Jain, Dhruv, et al.
Publicado: (2023)

Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis
por: Hitchon, Carol A., et al.
Publicado: (2020)

The comorbidity and cognition in multiple sclerosis (CCOMS) neuroimaging protocol: Study rationale, MRI acquisition, and minimal image processing pipelines
por: Uddin, Md Nasir, et al.
Publicado: (2022)

Effect of mood and anxiety disorders on health care utilization in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2020)

Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases
por: Enns, Murray W., et al.
Publicado: (2018)

Neuropsychological and Structural Neuroimaging Outcomes in LGI1-Limbic Encephalitis: A Case Study
por: Joshi, Jarod, et al.
Publicado: (2022)

Systematic Review and Meta-analysis of Interventions for Depression and Anxiety in Persons With Rheumatoid Arthritis
por: Fiest, Kirsten M., et al.
Publicado: (2017)

Depressive symptom trajectories and polygenic risk scores in individuals with an immune-mediated inflammatory disease
por: Kowalec, Kaarina, et al.
Publicado: (2022)

Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease
por: Fiest, Kirsten M., et al.
Publicado: (2016)

Prevalence and Risk Factors of Substance Use Disorder in Rheumatoid Arthritis
por: Kowalec, Kaarina, et al.
Publicado: (2021)

Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study
por: Marrie, Ruth Ann, et al.
Publicado: (2018)

Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data
por: Marrie, Ruth Ann, et al.
Publicado: (2017)

Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Uptake of influenza vaccination among persons with inflammatory bowel disease, multiple sclerosis or rheumatoid arthritis: a population-based matched cohort study
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Prescription opioid use in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Impact of Psychiatric Comorbidity on Health Care Use in Rheumatoid Arthritis: A Population‐Based Study
por: Hitchon, Carol A., et al.
Publicado: (2020)

Switching to second line MS disease-modifying therapies is associated with decreased relapse rate
por: Marriott, James John, et al.
Publicado: (2023)

Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease
por: Carney, Heather, et al.
Publicado: (2020)

Potential Pitfalls of Using Fractional Anisotropy, Axial Diffusivity, and Radial Diffusivity as Biomarkers of Cerebral White Matter Microstructure
por: Figley, Chase R., et al.
Publicado: (2022)

Functional MRI activation in white matter during the Symbol Digit Modalities Test
por: Gawryluk, Jodie R., et al.
Publicado: (2014)

Sensorimotor integration assessment by the Symbol-Digit modalities test in patients with Parkinson’s disease
por: Alamri, Yassar, et al.
Publicado: (2019)

Establishing the consistency of a voice recognition symbol digit modalities test analogue
por: Wishart, Margaret, et al.
Publicado: (2023)

Incidence of Adverse Psychiatric Events During Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review
por: Jain, Avni, et al.
Publicado: (2019)

Probabilistic White Matter Atlases of Human Auditory, Basal Ganglia, Language, Precuneus, Sensorimotor, Visual and Visuospatial Networks
por: Figley, Teresa D., et al.
Publicado: (2017)

Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis
por: Marrie, Ruth Ann, et al.
Publicado: (2018)

Periventricular and juxtacortical characterization of UManitoba-JHU functionally defined human white matter atlas networks
por: Figley, Chase R., et al.
Publicado: (2023)

Normative Data for the Symbol Digit Modalities Test in Older White Australians and Americans, African-Americans, and Hispanic/Latinos
por: Ryan, Joanne, et al.
Publicado: (2020)

Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
por: Benedict, Ralph HB, et al.
Publicado: (2017)

Smartphone-based symbol-digit modalities test reliably captures brain damage in multiple sclerosis
por: Pham, Linh, et al.
Publicado: (2021)

Computerized Symbol Digit Modalities Test in a Swiss Pediatric Cohort Part 1: Validation
por: Hochstrasser, Céline, et al.
Publicado: (2021)

The influence of math anxiety on symbolic and non-symbolic magnitude processing
por: Dietrich, Julia F., et al.
Publicado: (2015)

Differing trends in the incidence of vascular comorbidity in MS and the general population
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

The Multiple Sclerosis Functional Composite and Symbol Digit Modalities Test as outcome measures in pediatric multiple sclerosis
por: Brenton, J. Nicholas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hsftlv7osn69bgmivv87ac0ict